141 related articles for article (PubMed ID: 22773299)
1. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation.
Iioka F; Sada R; Maesako Y; Nakamura F; Ohno H
Int J Hematol; 2012 Sep; 96(3):364-9. PubMed ID: 22773299
[TBL] [Abstract][Full Text] [Related]
2. Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses.
Pollara CP; Piccinelli G; Rossi G; Cattaneo C; Perandin F; Corbellini S; Tomasi DD; Bonfanti C
BMC Infect Dis; 2013 Mar; 13():127. PubMed ID: 23496867
[TBL] [Abstract][Full Text] [Related]
3. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients.
Reid G; Huprikar S; Patel G; Razonable RR; Mossad S; Levi M; Gregg K; Shoham S; Humar A; Adams W; Kumar D
Transpl Infect Dis; 2013 Oct; 15(5):487-92. PubMed ID: 23890293
[TBL] [Abstract][Full Text] [Related]
4. Oseltamivir resistance in adult oncology and hematology patients infected with pandemic (H1N1) 2009 virus, Australia.
Tramontana AR; George B; Hurt AC; Doyle JS; Langan K; Reid AB; Harper JM; Thursky K; Worth LJ; Dwyer DE; Morrissey CO; Johnson PD; Buising KL; Harrison SJ; Seymour JF; Ferguson PE; Wang B; Denholm JT; Cheng AC; Slavin M
Emerg Infect Dis; 2010 Jul; 16(7):1068-75. PubMed ID: 20587176
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.
van der Vries E; Jonges M; Herfst S; Maaskant J; Van der Linden A; Guldemeester J; Aron GI; Bestebroer TM; Koopmans M; Meijer A; Fouchier RA; Osterhaus AD; Boucher CA; Schutten M
J Clin Virol; 2010 Jan; 47(1):34-7. PubMed ID: 19857993
[TBL] [Abstract][Full Text] [Related]
6. Detection of the rapid emergence of the H275Y mutation associated with oseltamivir resistance in severe pandemic influenza virus A/H1N1 09 infections.
Wang B; Dwyer DE; Blyth CC; Soedjono M; Shi H; Kesson A; Ratnamohan M; McPhie K; Cunningham AL; Saksena NK
Antiviral Res; 2010 Jul; 87(1):16-21. PubMed ID: 20385168
[TBL] [Abstract][Full Text] [Related]
7. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
[TBL] [Abstract][Full Text] [Related]
8. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit.
Yue MC; Collins JT; Subramoniapillai E; Kennedy GA
Asia Pac J Clin Oncol; 2017 Feb; 13(1):37-43. PubMed ID: 27730741
[TBL] [Abstract][Full Text] [Related]
9. Cluster of oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infections on a hospital ward among immunocompromised patients--North Carolina, 2009.
Chen LF; Dailey NJ; Rao AK; Fleischauer AT; Greenwald I; Deyde VM; Moore ZS; Anderson DJ; Duffy J; Gubareva LV; Sexton DJ; Fry AM; Srinivasan A; Wolfe CR
J Infect Dis; 2011 Mar; 203(6):838-46. PubMed ID: 21343149
[TBL] [Abstract][Full Text] [Related]
10. Oseltamivir-resistant pandemic A(H1N1) 2009 influenza viruses detected through enhanced surveillance in the Netherlands, 2009-2010.
Meijer A; Jonges M; Abbink F; Ang W; van Beek J; Beersma M; Bloembergen P; Boucher C; Claas E; Donker G; van Gageldonk-Lafeber R; Isken L; de Jong A; Kroes A; Leenders S; van der Lubben M; Mascini E; Niesters B; Oosterheert JJ; Osterhaus A; Riesmeijer R; Riezebos-Brilman A; Schutten M; Sebens F; Stelma F; Swaan C; Timen A; van 't Veen A; van der Vries E; te Wierik M; Koopmans M
Antiviral Res; 2011 Oct; 92(1):81-9. PubMed ID: 21767571
[TBL] [Abstract][Full Text] [Related]
11. Oseltamivir-resistant influenza A 2009 H1N1 virus in immunocompromised patients.
Couturier BA; Bender JM; Schwarz MA; Pavia AT; Hanson KE; She RC
Influenza Other Respir Viruses; 2010 Jul; 4(4):199-204. PubMed ID: 20836794
[TBL] [Abstract][Full Text] [Related]
12. Pandemic 2009 H1N1 influenza in patients with hematopoietic stem cell transplantation and hematologic malignancy: single center experience.
Tekgündüz E; Yüksel MK; Erbay C; Arıbaş B; Özdilekcan C; Arslan H; Koçubaba S; Demiriz I; Tetik A; Arda K; Altuntaş F
Oncology; 2010; 79(5-6):409-14. PubMed ID: 21455013
[TBL] [Abstract][Full Text] [Related]
13. Oseltamivir-resistant 2009 pandemic influenza A (H1N1) virus infection in two summer campers receiving prophylaxis--North Carolina, 2009.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(35):969-72. PubMed ID: 19745803
[TBL] [Abstract][Full Text] [Related]
14. Genotyping of a nosocomial outbreak of pandemic influenza A/H1N1 2009.
Rodríguez-Sánchez B; Alonso M; Catalán P; Sánchez Conde M; González-Candelas F; Giannella M; Bouza E; García de Viedma D
J Clin Virol; 2011 Oct; 52(2):129-32. PubMed ID: 21813318
[TBL] [Abstract][Full Text] [Related]
15. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
[TBL] [Abstract][Full Text] [Related]
16. Oseltamivir-resistant influenza A(H1N1)pdm09 virus associated with high case fatality, India 2015.
Tandel K; Sharma S; Dash PK; Parida M
J Med Virol; 2018 May; 90(5):836-843. PubMed ID: 29288584
[TBL] [Abstract][Full Text] [Related]
17. Rapid discrimination of oseltamivir-resistant 275Y and -susceptible 275H substitutions in the neuraminidase gene of pandemic influenza A/H1N1 2009 virus by duplex one-step RT-PCR assay.
Nakauchi M; Ujike M; Obuchi M; Takashita E; Takayama I; Ejima M; Oba K; Konomi N; Odagiri T; Tashiro M; Kageyama T;
J Med Virol; 2011 Jul; 83(7):1121-7. PubMed ID: 21567417
[TBL] [Abstract][Full Text] [Related]
18. Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection.
DeVries A; Wotton J; Lees C; Boxrud D; Uyeki T; Lynfield R
Influenza Other Respir Viruses; 2012 Nov; 6(6):e85-8. PubMed ID: 22243670
[TBL] [Abstract][Full Text] [Related]
19. Genetic microheterogeneity of emerging H275Y influenza virus A (H1N1) in Toronto, Ontario, Canada from the 2007-2008 respiratory season.
Eshaghi A; Bolotin S; Burton L; Low DE; Mazzulli T; Drews SJ
J Clin Virol; 2009 Jun; 45(2):142-5. PubMed ID: 19451021
[TBL] [Abstract][Full Text] [Related]
20. Oseltamivir-resistant pandemic (H1N1) 2009 virus, South Korea.
Yi H; Lee JY; Hong EH; Kim MS; Kwon D; Choi JH; Choi WY; Kim KS; Lee JK; Oh HB; Kang C
Emerg Infect Dis; 2010 Dec; 16(12):1938-42. PubMed ID: 21122225
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
